Research Analysts Set Expectations for Medtronic Q1 Earnings

Medtronic plc (NYSE:MDT - Free Report) - William Blair cut their Q1 2026 earnings estimates for Medtronic in a research report issued on Wednesday, May 21st. William Blair analyst M. Andrew now forecasts that the medical technology company will post earnings of $1.23 per share for the quarter, down from their prior forecast of $1.33. The consensus estimate for Medtronic's current full-year earnings is $5.46 per share. William Blair also issued estimates for Medtronic's Q2 2026 earnings at $1.33 EPS, Q3 2026 earnings at $1.37 EPS, Q4 2026 earnings at $1.60 EPS, FY2026 earnings at $5.54 EPS, Q1 2027 earnings at $1.33 EPS, Q2 2027 earnings at $1.39 EPS, Q4 2027 earnings at $1.76 EPS and FY2027 earnings at $5.94 EPS.

MDT has been the topic of a number of other research reports. Truist Financial dropped their price objective on Medtronic from $93.00 to $90.00 and set a "hold" rating on the stock in a research note on Friday, April 11th. Citigroup upgraded Medtronic from a "neutral" rating to a "buy" rating and upped their price target for the company from $92.00 to $107.00 in a research report on Tuesday, March 4th. Wall Street Zen downgraded Medtronic from a "buy" rating to a "hold" rating in a research note on Saturday. Needham & Company LLC restated a "hold" rating on shares of Medtronic in a report on Monday, May 19th. Finally, Robert W. Baird cut their price objective on shares of Medtronic from $94.00 to $92.00 and set a "neutral" rating for the company in a report on Thursday, May 22nd. One investment analyst has rated the stock with a sell rating, nine have issued a hold rating, seven have assigned a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of "Hold" and a consensus price target of $96.07.

Medtronic Trading Up 0.6%

MDT stock traded up $0.46 during midday trading on Friday, reaching $81.14. The company's stock had a trading volume of 8,294,265 shares, compared to its average volume of 6,817,710. The business's 50-day simple moving average is $84.84 and its 200-day simple moving average is $86.35. The company has a quick ratio of 1.39, a current ratio of 1.90 and a debt-to-equity ratio of 0.48. The stock has a market cap of $104.07 billion, a PE ratio of 24.66, a price-to-earnings-growth ratio of 2.22 and a beta of 0.81. Medtronic has a 52 week low of $75.96 and a 52 week high of $96.25.

Medtronic (NYSE:MDT - Get Free Report) last released its earnings results on Wednesday, May 21st. The medical technology company reported $1.62 earnings per share for the quarter, topping analysts' consensus estimates of $1.58 by $0.04. Medtronic had a return on equity of 14.07% and a net margin of 12.83%. The business had revenue of $8.93 billion for the quarter, compared to the consensus estimate of $8.81 billion. During the same period last year, the business earned $1.46 earnings per share. The firm's revenue for the quarter was up 3.9% compared to the same quarter last year.

Institutional Inflows and Outflows

A number of hedge funds and other institutional investors have recently modified their holdings of the company. Norges Bank bought a new stake in shares of Medtronic during the fourth quarter valued at approximately $1,163,580,000. Raymond James Financial Inc. acquired a new stake in shares of Medtronic in the fourth quarter worth $852,732,000. Beutel Goodman & Co Ltd. acquired a new position in Medtronic in the fourth quarter valued at approximately $377,169,000. Boston Partners boosted its stake in shares of Medtronic by 122.8% during the 1st quarter. Boston Partners now owns 6,912,055 shares of the medical technology company's stock worth $619,460,000 after acquiring an additional 3,809,450 shares in the last quarter. Finally, Ameriprise Financial Inc. increased its holdings in Medtronic by 28.8% in the 1st quarter. Ameriprise Financial Inc. now owns 15,481,028 shares of the medical technology company's stock worth $1,391,141,000 after acquiring an additional 3,461,221 shares in the last quarter. 82.06% of the stock is currently owned by institutional investors.

Medtronic Increases Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 11th. Investors of record on Friday, June 27th will be paid a dividend of $0.71 per share. This represents a $2.84 annualized dividend and a yield of 3.50%. This is a boost from Medtronic's previous quarterly dividend of $0.70. The ex-dividend date of this dividend is Friday, June 27th. Medtronic's dividend payout ratio (DPR) is presently 78.45%.

Medtronic Company Profile

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients worldwide. Its Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software.